Back

Learner’s Digest International (TM)

  • Cholangitis
  • Cholangitis, Sclerosing
  • Liver Cirrhosis, Biliary
  • Non-alcoholic Fatty Liver Disease

Cholangitis/Fatty Liver Disease

The goal of this program is to improve the diagnosis and man agement of primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) and alcoholic and nonalcoholic fatty liver disease (NAFLD). After hearing and assimilating this pro gram, the clinician will be better able to: 1. Diagnose PSC and PBC. 2. Select appropriate treatment strategies for PSC and PBC. 3. Identify factors that influence the prognosis of a patient with PSC. 4. Elaborate on the advantages of lifestyle modifications in NAFLD management. 5. Analyze the potential benefits and limitations of current pharmacologic therapies for alcoholic and nonalcoholic fatty liver disease.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABIM — Medical KnowledgeUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    May 8, 2027 7 months left